Lead Edge Capital Management’s Enfusion ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-2,409,967
Closed -$26.9M – 11
2025
Q1
$26.9M Hold
2,409,967
– – 8.16% 6
2024
Q4
$24.8M Hold
2,409,967
– – 8.4% 6
2024
Q3
$22.9M Buy
2,409,967
+674,416
+39% +$5.82M 6.62% 6
2024
Q2
$14.8M Buy
1,735,551
+884,584
+104% +$8.09M 4.72% 8
2024
Q1
$7.87M Buy
+850,967
New +$7.49M 2.42% 9

Other funds holding ENFN

Lead Edge Capital Management's ENFN Position: Q2 2025 in Review

Lead Edge Capital Management sold out of Enfusion (ENFN) in Q2 2025, closing a stake of 2,409,967 shares — an estimated $26.9M sold.

Lead Edge Capital Management first reported a position in ENFN in Q1 2024 and held it in 5 quarters. The position peaked at $26.9M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Lead Edge Capital Management reported no remaining Enfusion position as of Q2 2025 after selling out during the quarter.
  • Lead Edge Capital Management sold 2,409,967 Enfusion shares in Q2 2025, an estimated $26.9M.
  • Lead Edge Capital Management first reported a position in Enfusion in Q1 2024 and held it in 5 quarters.
  • Lead Edge Capital Management's Enfusion position peaked at $26.9M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion as of Q2 2025.

Based on Lead Edge Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.